Effectiveness of LateINaVersus PeakINaBlock in the Setting of Ventricular Fibrillation.
From the Lankenau Institute for Medical Research (A.B., C.A.), Lankenau Heart Institute (C.A.), Wynnewood, PA; and Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA (A.B.).
Alexander
A
Burashnikov
From the Lankenau Institute for Medical Research (A.B., C.A.), Lankenau Heart Institute (C.A.), Wynnewood, PA; and Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA (A.B.). cantzelevitch@gmail.com.
Charles
C
Antzelevitch
D000818:Animals; D006352:Heart Ventricles; D011817:Rabbits; D012964:Sodium; D026941:Sodium Channel Blockers; D014693:Ventricular Fibrillation
D026941:Sodium Channel Blockers; D012964:Sodium
Editorials; antiarrhythmic drugs; channels; electrophysiology; isoproterenol; pharmacology; sodium